FDA Clears ReAlta Life Sciences’ Phase 2 STAR Trial of RLS-0071 in Neonates with Hypoxic-Ischemic Encephalopathy
RLS-0071 is ReAlta’s lead dual-action complement inhibitor and innate anti-inflammatory [...]
RLS-0071 is ReAlta’s lead dual-action complement inhibitor and innate anti-inflammatory [...]
For Immediate Release: March 28, 2022 Contact: Dan Girouard, 757.728.5169 [...]
From SBA Starting immediately, Agency extends additional relief to small [...]
NEW YORK, March 9, 2022 -- Instant Teams, the remote talent [...]
The current Russian invasion of Ukraine has caused anxiety, financial [...]
New position ensures access to opportunities created by the Advanced [...]
-Nationally recognized ecosystem development organization to provide capacity building to [...]
$1.5M Will be Awarded to Support the Expansion of the [...]
New talent will leverage regional mentors to help more entrepreneurs [...]
VIRGINIA BEACH, Va. (Feb. 1, 2022) — The City of Virginia [...]